Takeda's Dengue Vaccine Candidate Associated with Reduced Incidence of Dengue in Children and Adolescents
Drug Discovery and Development ,
Takeda announced that data from an 18-month interim analysis of the ongoing Phase 2 DEN-204 trial of its live, attenuated…